Alani Sulaimon Akanmu
Overview
Explore the profile of Alani Sulaimon Akanmu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogunsola F, Sekoni A, Akanmu A, Adeyemo W, Osuntoki A, Manga-Atangana B, et al.
BMC Med Educ
. 2023 Jul;
23(1):522.
PMID: 37474931
Background: A research and training program (RTP) was carried out to build the capacity of faculty and improve the culture of research in the College of Medicine, University of Lagos...
2.
Abudiore O, Amamilo I, Campbell J, Eigege W, Harwell J, Conroy J, et al.
PLoS One
. 2023 May;
18(5):e0284767.
PMID: 37196012
Nigeria adopted dolutegravir (DTG) as part of first line (1L) antiretroviral therapy (ART) in 2017. However, there is limited documented experience using DTG in sub-Saharan Africa. Our study assessed DTG...
3.
Afolabi B, Makwe C, Okunade K, Akanmu O, Akase I, Otokiti O, et al.
Afr Health Sci
. 2022 Nov;
22(2):75-78.
PMID: 36407333
Coronavirus disease 2019 (COVID-19) presents with symptoms that may be mild or severe. The individual with the severe form of the disease usually presents with a constellation of respiratory symptoms...
4.
Aderemi-Williams R, Razaq A, Abah I, Opanuga O, Akanmu A
J Int Assoc Provid AIDS Care
. 2021 Dec;
20:23259582211062754.
PMID: 34881662
In Nigeria, there is a paucity of data on knowledge and experiences of adolescents and young adults (AYAs) with HIV and ART, as well as their challenges maintaining optimal adherence....
5.
Usman S, Oreagba I, Kadri M, Adewumi O, Akinyede A, Agbaje E, et al.
Eur J Clin Pharmacol
. 2021 Mar;
77(9):1341-1348.
PMID: 33755736
Purpose: Atazanavir-ritonavir (ATVr)-based antiretroviral therapy and artemether-lumefantrine (AL) are commonly used drugs for the treatment of human immune deficiency virus (HIV) infection and malaria respectively. However, interaction of both drugs,...
6.
Hou L, Mehta S, Christian E, Joyce B, Lesi O, Anorlu R, et al.
J Glob Health
. 2020 Nov;
10(2):020366.
PMID: 33214886
No abstract available.
7.
Akang E, Dosumu O, Okoko I, Faniyan O, Oremosu A, Akanmu A
Toxicol Res (Camb)
. 2020 Nov;
9(5):601-608.
PMID: 33178420
Combination antiretroviral therapy (cART), which is a lifelong therapy for people living with human immunodeficiency virus, has been associated with nephrotoxicity and hepatotoxicity leading to its discontinuation. This study aimed...
8.
Usman S, Oreagba I, Akinyede A, Agbaje E, Akinleye M, Onwujuobi A, et al.
J Pharmacol Sci
. 2020 Sep;
144(3):95-101.
PMID: 32921396
Patients living with HIV in malarial endemic regions may experience clinically significant drug interaction between antiretroviral and antimalarial drugs. Effects of nevirapine (NVP), efavirenz (EFV) and lopinavir/ritonavir (LPVr) on lumefantrine...
9.
Ogbenna A, Meloni S, Inzaule S, Hamers R, Sigaloff K, Osibogun A, et al.
PLoS One
. 2020 Aug;
15(8):e0238027.
PMID: 32841264
Introduction: HIV is a highly diverse virus with significant genetic variability which may confer biologic differences that could impact on treatment outcomes. Materials And Methods: We studied the association between...
10.
Akang E, Dosumu O, Afolayan S, Agumah R, Akanmu A
J Chem Neuroanat
. 2020 Jun;
109:101838.
PMID: 32569723
Background And Aim: Neurodegeneration has been associated with the use of combination antiretroviral therapy (cART). This study is aimed at determining if any constituent of cART can induce cerebellar limb...